Cancer Research Centre News
2021 may not have been the year anyone expected, with COVID-19 still making its presence known in our lives and around the world.
But a lot of progress has still been made. From promising new cancer drugs to trialling a cancer blood test, here are some of the top good news stories from the year.
More than 600 people in England with a form of lung cancer could benefit from the innovative drug osimertinib (Tagrisso) after its approval by the National Institute for Health and Care Excellence (NICE).
The drug will now be available to people with early-stage non small cell lung cancer (NSCLC) who have had surgery to remove their tumour that has errors in a gene called EGFR.
An immunotherapy combination could be better than standard 鈥楨xtreme鈥� chemotherapy as first-line treatment for some patients with relapsed or metastatic head and neck cancer, or both, a major phase III trial suggests.